Medeon Biodesign, Inc. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was TWD 68.96 million compared to TWD 123.06 million a year ago. Net income was TWD 2,078.19 million compared to net loss of TWD 192.74 million a year ago.

Basic loss per share from continuing operations was TWD 7 compared to TWD 4.12 a year ago. Diluted loss per share from continuing operations was TWD 7.12 compared to TWD 4.12 a year ago. Basic earnings per share was TWD 28.54 compared to basic loss per share of TWD 2.65 a year ago.

Diluted earnings per share was TWD 28.42 compared to diluted loss per share of TWD 2.65 a year ago.